Publications

5808 Results

Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer

Authors
J Sparano;F Zhao;S Martino;J Ligibel;EA Perez;T Saphner;AC Wolff;G Sledge;W Wood;NE Davidson
Journal / Conference
Journal of Clinical Oncology Jul 20;33(21):2353-2360
Year
2015
Research Committee(s)
Breast
PMID
PMID26077235
PMC
PMC4500829
Study Number(s)
E1199

Phase 1 Trial of G-CSF, cladribine, cytarabine, and dose-escalated mitoxantrone (G-CLAM) in adults with newly diagnosed AML or high-risk MDS

Authors
A Anwar;A Halpern;BL Scott;PS Becker;M Othus;PC Hendrie;EM Ranker;A Perdue;TL Chen;SA Buckley;KF Orlowski;MA Powell;E Estey;RB Walter
Journal / Conference
European Hematology Association Annual Meeting (June 11-14, 2015, Vienna, Austria), poster;
Year
2015
Research Committee(s)
Leukemia
Study Number(s)
S0106

Methods to standardize a multicenter acupuncture trial protocol to reduce aromatase inhibitor-related joint symptoms in breast cancer patients

Authors
H Greenlee;K Crew;J Capodice;D Awad;A Jeffres;J Unger;D Lew;L Hansen;FL Meyskens;JL Wade;DL Hershman
Journal / Conference
Journal of Acupuncture and Meridian Studies Jun;8(3):152-158
Year
2015
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID26100070
PMC
PMC4705910
Study Number(s)
S1200

Prospective analysis of antigen-specific immunity, stem cell antigens and immune checkpoints in monoclonal gammopathy

Authors
M Dhodapkar;R Sexton;R Das;L Zhang;R Sundaram;S Soni;J Crowley;RZ Orlowski;B Barlogie
Journal / Conference
Blood, Nov 26;126(22):2475-2478
Year
2015
Research Committee(s)
Myeloma
PMID
PMID26468228
PMC
PMC4661169
Study Number(s)
S0120

Results of a randomized phase II trial of R-HCVAD vs. R-bendamustine followed by autologous stem cell transplants for patients with mantle cell lymphoma: US intergroup study S1106

Authors
R Chen;H Li;S Bernstein;L Rimsza;S Forman;L Constine;TC Shea;A Cashen;Blum;TS Fenske;P Barr;M Leblanc;RI Fisher;S Smith;J Friedberg
Journal / Conference
Hematological Oncology 33: (Suppl S1, abst. 062), p.132; International Conference on Malignant Lymphoma (June 17-20, 2015, Lugano, Switzerland), oral;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
S1106

Adjuvant ovarian suppression in premenopausal breast cancer

Authors
PA Francis;MM Regan;GF Fleming;I Lang;E Ciruelos;M Bellet;HR Bonnefoi;M Climent;GA Da Prada;HJ Burstein;S Martino;NE Davidson;CE Geyer;BA Walley;R Coleman;P Kerbrat;S Buchholz;J Ingle;E Winer;M Rabaglio-Poretti;B Ruepp;A Giobbie-Hurder;KN Price;M Colleoni;G Viale;AS Coates;A Goldhirsch;G Gelber
Journal / Conference
New England Journal of Medicine Jan 29;372(5):436-446
Year
2015
Research Committee(s)
Breast
PMID
PMID25495490
PMC
PMC4341825

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the north central cancer treatment group N9831 adjuvant trastuzumab trial

Authors
EA Perez;EA Thompson;KV Ballman;SK Anderson;Y Asmann;K Kalari;J Eckel-Passow;AC Dueck;KS Tenner;J Jenn;J-B Fan;X Geiger;A McCullough;B Chen;RB Jenkins;G Sledge;E Winer;JR Gralow;MM Reinholz
Journal / Conference
Journal of Clinical Oncology Mar 1;33(7):701-708
Year
2015
Research Committee(s)
Breast
PMID
PMID25605861
PMC
PMC4334774
Study Number(s)
N9831

Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia

Authors
B Medeiros;M Othus;M Fang;F Appelbaum;H Erba
Journal / Conference
Haematololgica Mar;100(3):331-335
Year
2015
Research Committee(s)
Leukemia
PMID
PMID25527568
PMC
PMC4349271
Study Number(s)
S0106, S0112, S0301, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9918

Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial

Authors
F von Rundstedt;DA Mata;S Groshen;J Stein;D Skinner;WM Stadler;RJ Cote;ON Kryvenko;G Godoy;S Lerner
Journal / Conference
British Journal of Urology International Jul 116(1):44-49
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID25413313
PMC
PMC4524781
Study Number(s)
4B951

Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial

Authors
S Lui;J-A Chapman;MJ Burnell;MN Levine;KI Pritchard;TJ Whelan;RS Rugo;K Albain;EA Perez;S Virk;G Barry;D Gao;P O'Brien;L Shepherd;TO Nielsen;KA Gelmon
Journal / Conference
Breast Cancer Research and Treatment Jan;149(2):439-448, 2015
Year
2015
Research Committee(s)
Breast
PMID
PMID25552364